Janux Therapeutics - Immunotherapies for Cancer
  • About
    • Overview
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Scientific Publications
  • Pipeline
    • Programs
    • TRACTr
      • JANX007 – PSMA-TRACTr
      • JANX008 – EGFR-TRACTr
      • TROP2-TRACTr
    • TRACIr
      • PD-L1xCD28
  • Partners
  • Careers
  • Investors & Media
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Document
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contact
  • Contact
page headd=er

About Janux Therapeutics

The next generation of
immunotherapies for cancer

  • About
    • Overview
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Scientific Publications
  • Pipeline
    • Programs
    • TRACTr
      • JANX007 – PSMA-TRACTr
      • JANX008 – EGFR-TRACTr
      • TROP2-TRACTr
    • TRACIr
      • PD-L1xCD28
  • Partners
  • Careers
  • Investors & Media
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Document
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contact
  • Contact

Scientific Advisory Board

Mark M. Davis, Ph.D.

Charles S. Craik, Ph.D.

Greg Weiss, Ph.D.

Charles Hart, Ph.D.

Jennifer Maynard, Ph.D.

  • About |
  • Technology |
  • Pipeline |
  • Partners |
  • Careers |
  • Investors & Media |
  • Contact |

Copyright ©2022 Janux Therapeutics | Terms of Use | Privacy Policy

logo
  • About
    • Overview
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Scientific Publications
  • Pipeline
    • Programs
    • TRACTr
      • JANX007 – PSMA-TRACTr
      • JANX008 – EGFR-TRACTr
      • TROP2-TRACTr
    • TRACIr
      • PD-L1xCD28
  • Partners
  • Careers
  • Investors & Media
    • News
    • Events & Presentations
      • Events
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Document
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contact
  • Contact